Published • loading... • Updated
Get Double the Production of AVT02
Summary by RÚV
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Alvotech has received the approval of the annex to the marketing license in the US market for AVT02, which is similar to the Humira life-saving product. The announcement from the company says that this approval from the Food and Drug Administration of the United States means that production can be doubled for the US market in the company's facility in Reykjavík.
·Reykjavík, Iceland
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
